These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

585 related items for PubMed ID: 25491139

  • 1. Different expression of FoxM1 in human benign and malignant pleural effusion.
    Tang Z, Li H, Zhu H, Bai C.
    Med Oncol; 2015 Jan; 32(1):312. PubMed ID: 25491139
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Use of a panel of tumor markers (carcinoembryonic antigen, cancer antigen 125, carbohydrate antigen 15-3, and cytokeratin 19 fragments) in pleural fluid for the differential diagnosis of benign and malignant effusions.
    Porcel JM, Vives M, Esquerda A, Salud A, Pérez B, Rodríguez-Panadero F.
    Chest; 2004 Dec; 126(6):1757-63. PubMed ID: 15596670
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Assessment of a panel of tumor markers for the differential diagnosis of benign and malignant effusions by well-based reverse phase protein array.
    Braunschweig T, Chung JY, Choi CH, Cho H, Chen QR, Xie R, Perry C, Khan J, Hewitt SM.
    Diagn Pathol; 2015 May 29; 10():53. PubMed ID: 26022333
    [Abstract] [Full Text] [Related]

  • 9. Limitations of detection of malignancy in pleural effusions using ELISA-based TRAP assay: comparison with cytological examination.
    Lee WY.
    Cytopathology; 2005 Oct 29; 16(5):227-32. PubMed ID: 16181308
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Procalcitonin as a diagnostic marker in differentiating parapneumonic effusion from tuberculous pleurisy or malignant effusion.
    Lee SH, Lee EJ, Min KH, Hur GY, Lee SY, Kim JH, Shin C, Shim JJ, In KH, Kang KH, Lee SY.
    Clin Biochem; 2013 Oct 29; 46(15):1484-8. PubMed ID: 23570862
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Diagnostic value of the combined determination of carcinoembryonic antigen (CEA) in pleural effusion and serum with an enzyme immunoassay (EIA). Sensitivity, specificity and relation to tumor type].
    Klech H, Rona G, Hutter C, Bayer PM, Kummer F.
    Wien Klin Wochenschr; 1986 Sep 12; 98(17):564-73. PubMed ID: 3020811
    [Abstract] [Full Text] [Related]

  • 17. Diagnostic value of three tumor markers determined in pleural effusions.
    Conejo JR, Benedito JE, Jimenez A, Menchen M, Cano J, Granizo V, Larrodera L.
    Eur J Clin Chem Clin Biochem; 1996 Feb 12; 34(2):139-42. PubMed ID: 8833646
    [Abstract] [Full Text] [Related]

  • 18. Pleural fluid mesothelin for the differential diagnosis of exudative pleural effusions.
    Alemán C, Manuel Porcel J, Ma Segura R, Alegre J, Esquerda A, Ruiz E, Bielsa S, de Sevilla TF.
    Med Clin (Barc); 2009 Oct 03; 133(12):449-53. PubMed ID: 19783262
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.